Featured Research

from universities, journals, and other organizations

Most at-risk patients don't adhere to statin treatment, despite real benefits

Date:
May 15, 2011
Source:
North Carolina State University
Summary:
The vast majority of patients at high risk for heart disease or stroke do a poor job of taking statins as prescribed, a new study suggests. That's especially unfortunate, because the same study shows that taking statins can significantly increase the quality and length of those patients' lives.

A new study from North Carolina State University shows that the vast majority of patients at high risk for heart disease or stroke do a poor job of taking statins as prescribed. That's especially unfortunate, because the same study shows that taking statins can significantly increase the quality and length of those patients' lives.

"We found that only 48 percent of patients who have been prescribed statins are taking their prescribed dose on a regular basis after one year -- and that number dips to approximately 27 percent after 10 years," says Jennifer Mason, a Ph.D. student at NC State and lead author of a paper describing the study. Statins are a component of many current cardiovascular medical treatment guidelines. They lower cholesterol levels and may significantly reduce the risk of heart attack and stroke, particularly in patients that are considered to be at high risk.

The researchers also found that, for high-risk patients, high adherence to a prescribed statin regimen may increase quality-adjusted life years (QALYs) by as much as 1.5 years compared to low adherence -- and up to two years compared to not taking statins at all. Low adherence means a patient is taking the statins irregularly or at less than the prescribed dosage. QALYs are established metrics for measuring the effect of health conditions, such as heart disease and stroke, on quality of life.

The study used operations research models to look specifically at patients who have type 2 diabetes, because they are at particularly high risk for heart disease, heart attack and stroke.

"These findings suggest that adherence-improving interventions -- such as patient education or electronic reminders to take medications -- can significantly improve the quality and length of life, particularly for high-risk patients," says Dr. Brian Denton, co-author of the paper and an associate professor in the Edward P. Fitts Department of Industrial & Systems Engineering at NC State.

The paper, "Optimizing Statin Treatment Decisions for Diabetes Patients in the Presence of Uncertain Future Adherence," is forthcoming from the journal Medical Decision Making. The research was funded by the Agency for Healthcare Research and Quality (AHRQ) and the National Science Foundation (NSF). The paper was co-authored by Dr. Darin England; Drs. Steven Smith and Nilay Shah of the Mayo Clinic College of Medicine; and Mr. Murat Kurt of the University of Pittsburgh.


Story Source:

The above story is based on materials provided by North Carolina State University. Note: Materials may be edited for content and length.


Cite This Page:

North Carolina State University. "Most at-risk patients don't adhere to statin treatment, despite real benefits." ScienceDaily. ScienceDaily, 15 May 2011. <www.sciencedaily.com/releases/2011/05/110512091814.htm>.
North Carolina State University. (2011, May 15). Most at-risk patients don't adhere to statin treatment, despite real benefits. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/05/110512091814.htm
North Carolina State University. "Most at-risk patients don't adhere to statin treatment, despite real benefits." ScienceDaily. www.sciencedaily.com/releases/2011/05/110512091814.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins